mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.5 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.5 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |